Wilson specializes in refining and developing computational network models for more efficient drug design through better identification of potential druggable targets based on their protein network effects. Her recent focus has been on utilizing this approach to prioritize novel targets for immune, oncology and schizophrenia indications. She has also developed PathFX, a novel algorithm, which is currently in use by the U.S. Food and Drug Administration.
Wilson received her Ph.D. in biological engineering from the Massachusetts Institute of Technology. She holds a postdoctoral appointment with SPARK, a program within the Chemical and Systems Biology Department at Stanford University. Prior to that, she was a postdoctoral fellow at the UC San Francisco-Stanford Center for Excellence in Regulatory Science and Innovation. Wilson has received many honors, including the Sanofi iDEA Award, the National Science Foundation Graduate Research Fellowship and Koch Cancer Graduate Fellowship. She will join UCLA Samueli in July 2021.